Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Cardiology Pharmacists’ Insights on Recognizing the Burden of NVAF and Role of Screening in Pharmacy Settings

In this podcast, expert cardiology pharmacists Dr Kathleen Lusk and Dr Stephanie Dwyer Kaluzna discuss the prevalence, burden, and consequences of undiagnosed NVAF. They will explore evidence-based methods for NVAF screening and provide strategies to incorporate these within various pharmacy settings.
Stephanie Dwyer Kaluzna, PharmD, BCCP
Kathleen A. Lusk, PharmD, BCPS, BCCP
Released: April 25, 2022

This podcast is the first in a series of three featuring cardiology pharmacists Kathleen A. Lusk, PharmD, BCPS, BCCP, and Stephanie Dwyer Kaluzna, PharmD, BCCP. In this episode, Drs Lusk and Dwyer Kaluzna provide an overview of nonvalvular atrial fibrillation (NVAF), including prevalence, burden, and consequences of undiagnosed NVAF and the role of pharmacists in screening for the condition in various pharmacy settings.

Information on this Educational Activity

Faculty

Kathleen A. Lusk, PharmD, BCPS, BCCP

Associate Professor
Vice Chair

Department of Pharmacy Practice
University of the incarnate Word Feik School of Pharmacy
Adjunct Assistant Professor
Clinical Pharmacy Specialist

Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, Texas

Kathleen A. Lusk, PharmD, BCPS, BCCP, has no relevant conflicts of interest to report.
Stephanie Dwyer Kaluzna, PharmD, BCCP

Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Sciences System
Chicago, Illinois

Stephanie Dwyer Kaluzna, PharmD, BCCP, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by ProCE, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Pfizer Alliance

Related Content

Dr. Katherine Di Palo discusses use of novel potassium binders for the management of hyperkalemia, from ProCE

Katherine Di Palo, PharmD Released: May 13, 2022

Expert faculty provide practical strategies for successful management of hyperkalemia from ProCE

Katherine Di Palo, PharmD Michelle Richardson, PharmD, BCPS Pharmacists: 1.5 contact hours (0.15 CEUs) Released: May 12, 2022 Expired: May 11, 2023

Podcast featuring expert pharmacist insights on engaging patients and the healthcare team in collaborative, shared decision-making in NVAF management, from ProCE

Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 26, 2022

Podcast featuring expert pharmacist insights on the use of DOAC therapy in NVAF for stroke prevention, from ProCE

Stephanie Dwyer Kaluzna, PharmD, BCCP Released: April 25, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings